Thyroid carcinoma: epidemiology, histology, and diagnosis.
作者信息
Shah Jatin P
机构信息
Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York.
出版信息
Clin Adv Hematol Oncol. 2015 Apr;13(4 Suppl 4):3-6.
Abstract
摘要
相似文献
1
Thyroid carcinoma: epidemiology, histology, and diagnosis.甲状腺癌：流行病学、组织学及诊断
Clin Adv Hematol Oncol. 2015 Apr;13(4 Suppl 4):3-6.
2
Thyroid carcinoma in Hiroshima and Nagasaki. I. Prevalence of thyroid carcinoma at autopsy.广岛和长崎的甲状腺癌。I. 尸检时甲状腺癌的患病率。
JAMA. 1969 Jul 7;209(1):65-70.
3
Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries.非髓样甲状腺癌患者一级亲属的甲状腺癌发病风险：来自五个北欧国家的联合研究。
基于组织学类型和诊断时的年龄。
J Med Genet. 2013 Jun;50(6):373-82. doi: 10.1136/jmedgenet-2012-101412. Epub 2013 Apr 13.
4
[Medullary carcinoma of the thyroid gland. Morphology, frequency, and clinical aspects].[甲状腺髓样癌。形态学、发病率及临床方面]
Schweiz Med Wochenschr. 1974 Apr 27;104(17):602-5 contd.
5
[Thyroid carcinoma in children (7 personal observations)].[儿童甲状腺癌（7例个人观察病例）]
Arch Kinderheilkd. 1969 Sep;179(3):236-58.
6
Overdiagnosing thyroid cancer. What's in a name?甲状腺癌的过度诊断。名称中有何含义？
Manag Care. 2014 May;23(5):25.
7
[Cancer of the thyroid in an endemic goiter area. Anatomo-clinical correlation].[地方性甲状腺肿地区的甲状腺癌。解剖学与临床的相关性]
Rev Argent Endocrinol Metab. 1969 Dec;15(4):161-78.
8
Papillary and follicular thyroid cancer: a selective approach to diagnosis and treatment.乳头状和滤泡状甲状腺癌：诊断与治疗的选择性方法
Annu Rev Med. 1981;32:73-91. doi: 10.1146/annurev.me.32.020181.000445.
9
Epidemiology and histology of malignant thyroid nodules in North East Region of Romania (Moldavia) before and after alimentary salt universal iodination.罗马尼亚东北地区（摩尔多瓦）全民食盐碘化前后甲状腺恶性结节的流行病学与组织学情况
Rev Med Chir Soc Med Nat Iasi. 2011 Jan-Mar;115(1):45-8.
10
Thyroid tumors: comments on their pathology with a report on the 12 year incidence in a private hospital.甲状腺肿瘤：对其病理学的评论及一家私立医院12年发病率报告
J La State Med Soc. 1967 Mar;119(3):91-4.
引用本文的文献
1
The Current Understanding of the Molecular Pathogenesis of Papillary Thyroid Cancer.甲状腺乳头状癌分子发病机制的当前认识
Int J Mol Sci. 2025 May 13;26(10):4646. doi: 10.3390/ijms26104646.
2
Influence of Tumor Laterality and Focality on Clinical Implications and Tumor Advancement in Well-Differentiated Thyroid Cancer.肿瘤侧别和灶性对分化型甲状腺癌临床意义及肿瘤进展的影响
Cancers (Basel). 2024 Dec 7;16(23):4109. doi: 10.3390/cancers16234109.
3
SIX1 expression and its clinicopathological significance: difference between classic and follicular variant papillary thyroid carcinoma.SIX1表达及其临床病理意义：经典型与滤泡状变异型甲状腺乳头状癌的差异
Thyroid Res. 2024 Dec 9;17(1):26. doi: 10.1186/s13044-024-00212-9.
4
Diagnostic sensitivity of fine-needle aspiration cytology in thyroid cancer.细针穿刺细胞学诊断在甲状腺癌中的敏感性。
Sci Rep. 2024 Oct 16;14(1):24216. doi: 10.1038/s41598-024-75677-7.
5
Racial-Ethnic Comparison of Treatment for Papillary Thyroid Cancer in the Military Health System.种族-民族比较在军事卫生系统中治疗甲状腺乳头状癌。
Ann Surg Oncol. 2024 Nov;31(12):8196-8205. doi: 10.1245/s10434-024-15941-2. Epub 2024 Jul 31.
6
Core needle biopsy for thyroid nodules assessment-a new horizon?用于甲状腺结节评估的粗针活检——新视野？
World J Clin Oncol. 2024 May 24;15(5):580-586. doi: 10.5306/wjco.v15.i5.580.
7
WHO 2022 updates on follicular cell and c-cell derived thyroid neoplasm.世卫组织 2022 年关于滤泡细胞和 C 细胞来源的甲状腺肿瘤更新。
J Med Life. 2024 Jan;17(1):15-23. doi: 10.25122/jml-2023-0270.
8
Unexpected focal fluorodeoxyglucose uptake in main organs; pass through or pass by?主要器官中意外的局灶性氟脱氧葡萄糖摄取；是穿过还是经过？
World J Clin Cases. 2024 Apr 16;12(11):1885-1899. doi: 10.12998/wjcc.v12.i11.1885.
9
GSG2 promotes thyroid cancer via stabilizing AURKB and activating AKT pathway.GSG2 通过稳定 AURKB 和激活 AKT 通路促进甲状腺癌。
Aging (Albany NY). 2024 Mar 4;16(6):5091-5107. doi: 10.18632/aging.205605.
10
Anoikis-related gene CDKN2A predicts prognosis and immune response and mediates proliferation and migration in thyroid carcinoma.失巢凋亡相关基因CDKN2A预测甲状腺癌的预后和免疫反应并介导其增殖与迁移。
Transl Oncol. 2024 Feb;40:101873. doi: 10.1016/j.tranon.2023.101873. Epub 2023 Dec 22.
本文引用的文献
1
Cancer statistics, 2014.癌症统计数据，2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
2
Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors.全球甲状腺癌发病率不断上升：流行病学与风险因素的最新情况
J Cancer Epidemiol. 2013;2013:965212. doi: 10.1155/2013/965212. Epub 2013 May 7.
3
Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure.日本原子弹爆炸幸存者甲状腺癌风险的长期趋势：暴露后 60 年。
Int J Cancer. 2013 Mar 1;132(5):1222-6. doi: 10.1002/ijc.27749. Epub 2012 Aug 16.
4
The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years.在美国，最常见的甲状腺乳头状癌现在是 45 岁以上患者的微癌。
Thyroid. 2011 Mar;21(3):231-6. doi: 10.1089/thy.2010.0137. Epub 2011 Jan 26.
5
Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study.在大型队列研究中，儿童癌症放疗后第二原发甲状腺癌的风险：来自儿童癌症幸存者研究的更新。
Radiat Res. 2010 Dec;174(6):741-52. doi: 10.1667/RR2240.1. Epub 2010 Oct 6.
6
Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.评估全甲状腺切除术和放射性碘残留消融后分化型甲状腺癌的复发风险：使用治疗反应变量来修正新的美国甲状腺协会分期系统预测的初始风险估计。
Thyroid. 2010 Dec;20(12):1341-9. doi: 10.1089/thy.2010.0178. Epub 2010 Oct 29.
7
Radiation-induced thyroid cancer: what we have learned from chernobyl.辐射诱发的甲状腺癌：我们从切尔诺贝利事故中学到的经验
Endocr Pathol. 2006 Winter;17(4):307-17. doi: 10.1007/s12022-006-0001-5.
8
Incidence and survival of Swedish patients with differentiated thyroid cancer.瑞典分化型甲状腺癌患者的发病率和生存率。
Int J Cancer. 2003 Sep 10;106(4):569-573. doi: 10.1002/ijc.11275.
9
Genome-wide appraisal of thyroid cancer progression.甲状腺癌进展的全基因组评估。
Am J Pathol. 2002 Nov;161(5):1549-56. doi: 10.1016/S0002-9440(10)64433-1.
10
Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.甲状腺癌的预后因素。一项基于人群的研究，涉及1973 - 1991年监测、流行病学和最终结果（SEER）项目中的15698例病例。
Cancer. 1997 Feb 1;79(3):564-73. doi: 10.1002/(sici)1097-0142(19970201)79:3<564::aid-cncr20>3.0.co;2-0.
Zotero 插件